Literature DB >> 9798740

Complex visual hallucinations. Clinical and neurobiological insights.

M Manford1, F Andermann.   

Abstract

Complex visual hallucinations may affect some normal individuals on going to sleep and are also seen in pathological states, often in association with a sleep disturbance. The content of these hallucinations is striking and relatively stereotyped, often involving animals and human figures in bright colours and dramatic settings. Conditions causing these hallucinations include narcolepsy-cataplexy syndrome, peduncular hallucinosis, treated idiopathic Parkinson's disease, Lewy body dementia without treatment, migraine coma, Charles Bonnet syndrome (visual hallucinations of the blind), schizophrenia, hallucinogen-induced states and epilepsy. We describe cases of hallucinosis due to several of these causes and expand on previous hypotheses to suggest three mechanisms underlying complex visual hallucinations. (i) Epileptic hallucinations are probably due to a direct irritative process acting on cortical centres integrating complex visual information. (ii) Visual pathway lesions cause defective visual input and may result in hallucinations from defective visual processing or an abnormal cortical release phenomenon. (iii) Brainstem lesions appear to affect ascending cholinergic and serotonergic pathways, and may also be implicated in Parkinson's disease. These brainstem abnormalities are often associated with disturbances of sleep. We discuss how these lesions, outside the primary visual system, may cause defective modulation of thalamocortical relationships leading to a release phenomenon. We suggest that perturbation of a distributed matrix may explain the production of similar, complex mental phenomena by relatively blunt insults at disparate sites.

Entities:  

Mesh:

Year:  1998        PMID: 9798740     DOI: 10.1093/brain/121.10.1819

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  86 in total

1.  The neural basis of Charles Bonnet hallucinations: a hypothesis.

Authors:  W Burke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-11       Impact factor: 10.154

2.  Charles Bonnet syndrome--elderly people and visual hallucinations.

Authors:  Anu Jacob; Sanjeev Prasad; Mike Boggild; Sanjeev Chandratre
Journal:  BMJ       Date:  2004-06-26

3.  Peduncular Hallucinosis as First Presentation of Juvenile Pilocytic Astrocytoma.

Authors:  Sugata Narayan Biswas; Souvik Biswas; Partha Pratim Chakraborty
Journal:  Indian J Pediatr       Date:  2015-11-09       Impact factor: 1.967

4.  Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.

Authors:  Maiya R Geddes; Yanmei Tie; John D E Gabrieli; Scott M McGinnis; Alexandra J Golby; Susan Whitfield-Gabrieli
Journal:  Cortex       Date:  2015-11-05       Impact factor: 4.027

5.  Visual and spatial positive phenomena in the neglected hemifield--a case report.

Authors:  Dario Grossi; Floriana Imperati; Giuseppe Carbone; Antonio Maiorino; Valentina Angelillo; Luigi Trojano
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

6.  Charles Bonnet syndrome in patients with glaucoma and good acuity.

Authors:  S A Madill; D H Ffytche
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 7.  Rapid eye movement sleep, non-rapid eye movement sleep, dreams, and hallucinations.

Authors:  Raffaele Manni
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

8.  Reassessment of the structural basis of the ascending arousal system.

Authors:  Patrick M Fuller; Patrick Fuller; David Sherman; Nigel P Pedersen; Clifford B Saper; Jun Lu
Journal:  J Comp Neurol       Date:  2011-04-01       Impact factor: 3.215

Review 9.  Charles Bonnet syndrome: two case reports and review of the literature.

Authors:  Alberto Lerario; Andrea Ciammola; Barbara Poletti; Floriano Girotti; Vincenzo Silani
Journal:  J Neurol       Date:  2013-02-05       Impact factor: 4.849

Review 10.  Psychiatric aspects of Parkinson's disease--an update.

Authors:  Anette Schrag
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.